德国季节性新冠疫苗接种的临床与经济效益:ROUTINE-COV19研究
结果显示接种与长新冠、呼吸道感染和新冠相关住院率降低相关,全因死亡率降低25%,医疗和间接成本更低,支持在地方性流行阶段继续实施国家免疫建议。
核心结论
- 在常规医疗中开展季节性新冠疫苗接种与显著的临床和经济效益相关,支持在SARS-CoV-2地方性流行阶段继续实施国家免疫建议。
主要发现
- 共匹配146132人(每组73066人)。
- 接种组长新冠发生率降低(RR 0.43;95%CI 0.26-0.70),呼吸道感染降低(RR 0.91;95%CI 0.87-0.95),新冠相关住院降低(RR 0.41;95%CI 0.31-0.54)。
- 接种组全因死亡率降低25%(HR 0.76;95%CI 0.70-0.82)。
临床怎么用
- 在地方性流行阶段可继续推荐季节性新冠疫苗接种,以降低长新冠、住院和死亡风险并节约医疗成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDVaccinations against COVID-19 were integrated into routine care in Germany in April 2023. However, evidence of the impact of seasonal vaccination remains limited.AIMTo assess the clinical and economic impact of COVID-19 vaccination in routine care during the early SARS-CoV-2-endemic phase in Germany.METHODSA retrospective cohort study using statutory health insurance data from two German federal states (Saxony and Thuringia), covering over 3 million individuals, was conducted. Adults aged ≥ 18 years vaccinated against COVID-19 between 1 September and 30 November 2023 were matched 1:1 with unvaccinated individuals using propensity scores. Outcomes during the 4-month follow-up included occurrence of SARS-CoV-2 infection, long COVID, other respiratory infections, hospitalisations, mortality, healthcare costs and indirect costs caused by sick leave. Rate and hazard ratios (RR, HR) with 95% confidence intervals (CI) were calculated. Sensitivity analyses tested robustness.RESULTSA total of 146,132 individuals (73,066 per group) were matched. COVID-19 vaccination was associated with reduced rates of long COVID (RR: 0.43; 95% CI: 0.26-0.70), respiratory infections (RR: 0.91; 95% CI: 0.87-0.95) and COVID-19-related hospitalisations (RR: 0.41; 95% CI: 0.31-0.54). All-cause mortality was 25% lower among COVID-19-vaccinated individuals (HR: 0.76; 95% CI: 0.70-0.82). Healthcare costs were lower in the vaccinated cohort, particularly for inpatient care, e.g. EUR 1 million savings in COVID-19-related hospitalisations. Indirect costs caused by sick leave were also reduced by EUR 1.3 million.CONCLUSIONSeasonal COVID-19 vaccinations in routine care settings were associated with substantial clinical and economic benefits. These real-world findings support continued implementation of national immunisation recommendations during the endemic phase of SARS-CoV-2 circulation.
引用
- Schmetz A, Knaul J, Müller S, et al. Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024. Euro Surveill. 2026. PMID: 42141891. doi:10.2807/1560-7917.ES.2026.31.15.2500672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。